-transparent.png){kind=logo}
Sulfamethazine (syn, sulfadimidine) is inactivated by conversion to its N-acetyl derivative. Individuals are phenotyped as either "rapid" or "slow" acetylators. We have tested the validity of this theory in a Nigerian population. The frequency distribution histograms of the percentage acetylsulfamethazine in urine and serum were found to be bimodal, indicating the existence of a genetic polymorphism as observed by earlier workers. A plot of the percentage of the drug acetylated in serum against that in urine of the same individual results in a satisfactory separation of the rapid and slow acetylator phenotypes. An incidence of the slow acetylator phenotype of 41% was observed in the Nigerian population tested. How this observation fits into the hypothesis that the slow frequency of the allele increases from the Arctic Circle toward the Equator is discussed.
L C Eze, and
O Obidoa
May 1981,
Xenobiotica; the fate of foreign compounds in biological systems,
L C Eze, and
O Obidoa
September 1990,
Zhongguo yao li xue bao = Acta pharmacologica Sinica,
L C Eze, and
O Obidoa
June 1993,
Pharmacogenetics,
L C Eze, and
O Obidoa
January 1980,
Clinical pharmacology and therapeutics,
L C Eze, and
O Obidoa
January 1984,
Drug intelligence & clinical pharmacy,
L C Eze, and
O Obidoa
January 1988,
Drug metabolism and disposition: the biological fate of chemicals,
L C Eze, and
O Obidoa
March 2016,
International journal of immunopathology and pharmacology,
L C Eze, and
O Obidoa
October 1989,
Die Pharmazie,
L C Eze, and
O Obidoa
December 2000,
Bulletin of experimental biology and medicine,
L C Eze, and
O Obidoa
July 1975,
The American journal of tropical medicine and hygiene,
